[Federal Register Volume 89, Number 39 (Tuesday, February 27, 2024)]
[Notices]
[Pages 14501-14503]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03889]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-24-0978; Docket No. CDC-2024-0013]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Emerging Infections Program 
(EIP). EIP is a population-based surveillance activity conducted via 
active, laboratory case finding that is used for detecting, 
identifying, and monitoring emerging pathogens.

DATES: CDC must receive written comments on or before April 29, 2024.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0013 by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;

[[Page 14502]]

    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Emerging Infections Program (EIP) (OMB Control No. 0920-0978, Exp. 
2/28/2026)--Revision--National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Emerging Infections Programs (EIPs) are population-based 
centers of excellence established through a network of state health 
departments collaborating with academic institutions; local health 
departments; public health and clinical laboratories; infection control 
professionals; and healthcare providers. EIPs assist in local, state, 
and national efforts to prevent, control, and monitor the public health 
impact of infectious diseases. Activities of the EIPs fall into the 
following general categories: (1) active surveillance; (2) applied 
public health epidemiologic and laboratory activities; (3) 
implementation and evaluation of pilot prevention/intervention 
projects; and (4) flexible response to public health emergencies. 
Activities of the EIPs are designed to: (1) address issues that the EIP 
network is particularly suited to investigate; (2) maintain sufficient 
flexibility for emergency response and new problems as they arise; (3) 
develop and evaluate public health interventions to inform public 
health policy and treatment guidelines; (4) incorporate training as a 
key function; and (5) prioritize projects that lead directly to the 
prevention of disease.
    A Revision is being submitted to make existing collection 
instruments clearer, consolidate forms and to add new forms. These 
forms will allow the EIP to better detect, identify, track changes in 
laboratory testing methodology, gather information about laboratory 
utilization in the EIP catchment area to ensure that all cases are 
being captured, and survey EIP staff to evaluate program quality.
    CDC requests OMB approval for an estimated 42,440 annual burden 
hours. There is no cost to respondents other than their time.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                              Average
                                                                                             Number of       Number of      burden  per   Current  total
            Type of  respondent               Form number             Form name             respondents    responses per   response  (in    burden  (in
                                                                                                            respondent        hours)          hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Health Department...................       ABC.100.1  ABCs Case Report Form.......              10             809           20/60            2697
                                                 ABC.100.2  ABCs Invasive Pneumococcal                10             127           10/60             212
                                                             Disease in Children and
                                                             Adults Case Report Form.
                                                 ABC.100.3  ABCs H. influenzae Neonatal               10               6           10/60              10
                                                             Sepsis Expanded
                                                             Surveillance Form.
                                                 ABC.100.4  ABCs Severe GAS Infection                 10             136           20/60             453
                                                             Supplemental Form.
                                                 ABC.100.5  ABCs Neonatal Infection                   10              37           20/60             123
                                                             Expanded Tracking Form.
                                                  FN.200.1  FoodNet Campylobacter.......              10             970           21/60            3395
                                                  FN.200.2  FoodNet Cyclospora..........              10              42           10/60              70
                                                  FN.200.3  FoodNet Listeria                          10              16           20/60              53
                                                             monocytogenes.
                                                  FN.200.4  FoodNet Salmonella..........              10             855           21/60            2993
                                                  FN.200.5  FoodNet Shiga toxin                       10             290           20/60             967
                                                             producing E. coli.
                                                  FN.200.6  FoodNet Shigella............              10             234           10/60             390
                                                  FN.200.7  FoodNet Vibrio..............              10              46           10/60              77
                                                  FN.200.8  FoodNet Yersinia............              10              55           10/60              92
                                                  FN.200.9  FoodNet Hemolytic Uremic                  10              10               1             100
                                                             Syndrome.
                                                 FN.200.10  FoodNet Clinical Laboratory               10              70           10/60             117
                                                             Practices and Testing
                                                             Volume.
                                                 FSN.300.1  FluSurv-Net Influenza                     15             727           25/60            4544
                                                             Hospitalization
                                                             Surveillance Network Case
                                                             Report Form.
                                                 FSN.300.2  FluSurv-Net Influenza                     14              16           10/60              37
                                                             Hospitalization
                                                             Surveillance Project
                                                             Vaccination Phone Script
                                                             and Consent Form (English/
                                                             Spanish).
                                                 FSN.300.3  FluSurv-Net Influenza                     14             126            5/60             147
                                                             Hospitalization
                                                             Surveillance Project
                                                             Provider Vaccination
                                                             History Fax Form (Children/
                                                             Adults).
                                                 FSN.300.4  FluSurv-NET Laboratory                    15              16           10/60              40
                                                             Survey.
                                                HAIC.400.1  HAIC--Multi-site Gram-                    11            1581           29/60            8406
                                                             Negative Surveillance
                                                             Initiative (MuGSI) Case
                                                             Report Form.
                                                HAIC.400.2  HAIC MuGSI CA CP-CRE Health               10              10           30/60              50
                                                             interview.
                                                HAIC.400.3  HAIC MuGSI Supplemental                   11               1           20/60               4
                                                             Surveillance Officer Survey.
                                                HAIC.400.4  HAIC--Invasive                            10             788           29/60            3809
                                                             Staphylococcus aureus
                                                             Infection Case Report Form.
                                                HAIC.400.5  HAIC--Invasive                            10              11            9/60              17
                                                             Staphylococcus aureus
                                                             Laboratory Survey.
                                                HAIC.400.6  HAIC--Invasive                            10               1         10.5/60               2
                                                             Staphylococcus aureus
                                                             Supplemental Surveillance
                                                             Officers Survey.

[[Page 14503]]

 
                                                HAIC.400.7  HAIC--CDI Case Report and                 10            1650           38/60           10450
                                                             Treatment Form.
                                                HAIC.400.8  HAIC--Annual Survey of                    10              16           17/60              45
                                                             Laboratory Testing
                                                             Practices for C. difficile
                                                             Infections.
                                                HAIC.400.9  HAIC--CDI Annual                          10               1           15/60               3
                                                             Surveillance Officers
                                                             Survey.
                                               HAIC.400.10  HAIC--Emerging Infections                 10              45            5/60              38
                                                             Program C. difficile
                                                             Surveillance Nursing Home
                                                             Telephone Survey (LTCF).
                                               HAIC.400.11  HAIC Candidemia Case Report               10             170           40/60            1133
                                                             Form.
                                               HAIC.400.12  HAIC--Laboratory Testing                  10              20           14/60              47
                                                             Practices for Candidemia
                                                             Questionnaire.
                                               HAIC.400.13  HAIC Death Ascertainment                  10               8         1440/60           1,920
                                                             Project.
                                                                                         ---------------------------------------------------------------
    Total.................................  ..............  ............................  ..............  ..............  ..............          42,440
--------------------------------------------------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-03889 Filed 2-26-24; 8:45 am]
BILLING CODE 4163-18-P